JPRN-UMIN000032361招募中未知
eoadjuvant chemoradiotherapy of GEM +S-1 for resectable pancreatic cancer : Phase II study - NACRT of GS for resectable pancreatic cancer
Yokohama City University School of Medicine Department of Gastroenterological Surgery0 个研究点目标入组 50 人开始时间: 2018年5月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Severe drug allergy 2) pulmonary fibrosis or interstitial pneumonitis 3) Uncontrolled watery diarrhea 4) Active infection 5) Severe disease 6) Pregnant females, possibly pregnant females
研究者
相似试验
已完成
1 期
Phase I study of GEM or S-1 adjuvant therapy after hemihepatectomy for biliary tract cancer (KHBO1003)JPRN-UMIN000004682Kansai Hepatobiliary Oncology Group (KHBO)6
尚未招募
3 期
eoadjuvant chemoradioation for resectable, non-metastasized ductal adenocarcinoma of the pancreasC25.0Head of pancreasDRKS00003893niversitätsklinikum Hamburg-Eppendorf410
已完成
2 期
eoadjuvant radiation therapy concurrent with S-1 followed by systemic Gemcitabine therapy for Borderline resectable pancreatic cancer patients; A phase2 studypancreatic cancerJPRN-UMIN000012293Hokkaido Pancreatic Cancer Study Group (HOPS)45
已完成
不适用
eoadjuvant radiation therapy concurrent with S-1 followed by systemic S-1/Gemcitabine therapy for Borderline resectable pancreatic cancer patients; A pilot studypancreatic cancerJPRN-UMIN000008888Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University Hospital30
已完成
1 期
Gemcitabine/TS-1 combination chemoradiotherapy for unresectable locally advanced pancreatic cancer(Phase I study)nresectable locally advanced pancreatic cancerJPRN-UMIN000005042Osaka Medical Center for Cancer and Cardiovascular Diseases Division of Hepatobiliary and Pancreatic Oncology24